Company news
Creo Medical Group Plc (LSE:CREO) news
Creo Medical Group Plc news releases on 6ix. Latest, Sep 30, 2026: Unaudited interim results
Press releases & updates
Unaudited interim results
September 30, 2026
H1-26 Trading Update
July 28, 2026
MicroBlate™ Flex exceeds 100 clinical cases
July 23, 2026
Appointment of Nominated Adviser /Corporate Broker
June 23, 2026
Posting of 2025 Annual Report and Notice of AGM
June 4, 2026
Proposed Placing to raise approximately £5.5m
May 22, 2026
MicroBlate™ Fine commercial update
May 7, 2026
SpydrBlade™ Flex used in novel BEAM procedures
May 5, 2026
KOL presentations on Creo Core Products at DDW
April 30, 2026
UK private hospital use Speedboat for cancer case
April 29, 2026
Positive Q1 trading update
April 22, 2026
Disposal and outsourcing of manufacturing
April 16, 2026
Appointment of Joint Corporate Broker
February 24, 2026
FY25 Trading Update
January 20, 2026
Award of Shares under Share Incentive Plan
January 14, 2026
Notice of Capital Markets Day
October 27, 2025
Capital Markets Day update
October 7, 2025
Creo Medical : 2025 Interim Results Presentation
September 25, 2025
Unaudited results for the six months ended 30 June
September 22, 2025
Holding(s) in Company
September 12, 2025
Notice of Results
September 11, 2025
Director/PDMR Share Dealing
August 12, 2025
Speedboat® patient testimonial
August 4, 2025
Award of Shares under SIP and Director Dealings
July 24, 2025
H1’25 Trading Update
July 21, 2025
MicroBlate™ Flex begins lung tumour clinical study
July 10, 2025
PDMR Options Revision
July 9, 2025
Change of Nominated Adviser
June 30, 2025
Result of AGM
June 26, 2025
U.S. FDA clearance for SpydrBlade™ Flex
June 11, 2025
Director/PDMR Shareholding
June 2, 2025
Posting of AR&R and Notice of AGM
May 30, 2025
US Reimbursement milestone for Speedboat procedure
May 28, 2025
Creo Medical : 2024 Final Results (19 May 2025)
May 23, 2025
Directorate changes
May 22, 2025
Final Results
May 19, 2025
Notice of investor presentations
May 6, 2025
Grant of Options
March 26, 2025
UK & EU Commercial launch of SpydrBlade™ Flex
March 20, 2025
Appointment of Nominated Adviser and sole Broker
March 6, 2025
FY24 Trading Update
February 17, 2025
Completion of sale of 51% interest in subsidiary
February 12, 2025
First Welsh adopter of Speedboat® technology
February 6, 2025
Total Voting Rights
February 3, 2025
First robotic-guided lung ablation cases commence
January 15, 2025
Director/PDMR Shareholding (Replacement)
October 24, 2024
Director/PDMR Share Dealings
October 21, 2024
Result of General Meeting & TVR
October 18, 2024
Result of Retail Offer
October 17, 2024
Extension of Retail Offer Closing Date
October 4, 2024